In vivo therapeutic effects of affinity-improved-TCR engineered T-cells on HBV-related hepatocellular carcinoma
Qi Liu(Guangzhou Institutes of Biomedicine and Health), Yuefei Ren(University of Science and Technology of China), Peipei Zhou(St. Jude Children's Research Hospital), Yaju Liu(University of Science and Technology of China), Wenxuan Cai(University of Wisconsin–Madison), Ye Tian(Central South University), Yi Li(Guangzhou Institutes of Biomedicine and Health), Wei Zhang(Capital Medical University), Yajing Zhang(Guangzhou Institutes of Biomedicine and Health), Zhaoduan Liang(Anhui University), Yifeng Bao(Fudan University), Yanyan Li(Chinese Academy of Sciences)
Cited by 42
Related Papers
The landscape of aging
|Science China Life Sciences|2022|404
Caffeine
|Unknown|2016|300
Caffeine: Toward Uniformed Representation and Acceleration for Deep Convolutional Neural Networks
|IEEE Transactions on Computer-Aided Design of Integrated Circuits and Systems|2018|268
mTOR signaling at the crossroads of environmental signals and T‐cell fate decisions
|Immunological Reviews|2020|188